[#1] Secure containment laboratory buildout (negative-pressure isolation wing, anterooms, sealed finishes, clinical exam/surgery room, centralized HEPA filtration). Estimate set to mid-range for retrofitted BSL-3+ suite.

[#2, #3, #4, #5, #7, #9, #10, #15, #30] Capital equipment package including specialized HVAC install, redundant AHUs/HEPA ($#2), Class III gloveboxes and biosafety cabinets ($#3), autoclave and effluent treatment skid ($#4), medical/surgical equipment ($#5), initial PAPR/PPE stock ($#7), security systems install ($#9/#10), dedicated secure van ($#15), and cold-chain/freezer hardware ($#30). Values are midpoints of provided ranges aggregated.

[#6, #19] Clinical laboratory instrumentation (microscopy, incubators, PCR, sequencer, flow cytometer) and initial animal-model development/setup. Sum reflects mid-to-upper range of stated one-time research buildout and model-establishment costs.

[#27] Initial redundancy/contingency fund for breach response, rapid deployment, mobile isolation units and emergency stockpile. Set as an initial reserve (mid-range $500k–$2M).

[#14] Initial BSL-3+ training, fit-testing, drills and practical certification for ~60 staff (est. ~$5k/person initial -> ~$300k).

[#9, #11, #12, #13] Ongoing payroll for core team: specialized clinical/research staff and biosafety officers (#11 ~$1.35M), nursing/clinical support (#12 ~$400k), and dedicated security guard payroll (#9/#13 ~$780k).

[#6, #18, #19, #20, #28, #32] Ongoing diagnostics, sequencing and lab consumables (#6/#18), animal colony and study costs (#19), experimental therapeutic development and trials (if ongoing) (#20), forensic/metagenomic analytics (#28), and R&D/countermeasure stockpile maintenance (#32). Aggregated mid-range annual budgeting for sustained research program.

[#21] Direct patient treatment costs (surgeries, inpatient stays, labs, pharmacotherapy) for an operational caseload (example: modest cohort of active patients).

[#2, #3, #4, #26] HVAC and HEPA maintenance, pressure-differential monitoring, glovebox/biosafety cabinet servicing, autoclave/service contracts, and routine decontamination/maintenance contracts.

[#24] Communications, legal retainers, records management and public-health liaison / cover-story maintenance budget (mid-range).

[#31] Annualized budgeting for potential small-scale remediation/response; large events would be budgeted as incidents but maintain a recurring preparedness fund.

[#5, #7, #8] Consumable surgical supplies, disposable PPE (gloves, gowns, cartridges), and routine sporicidal disinfectants. Mid-range annual consumption assumed.

[#16] Contracted incineration/neutralization costs for biocontaminated waste; mid-range annual estimate based on drum-throughput ranges provided.

[#15] Operating costs for secure transport (armored/escorted vehicle operations), certified biological packaging and per-transfer handling fees; annualized vehicle operating costs.

[#25] Environmental sampling, community surveillance, and periodic larger-area sweeps; annual baseline program costs.

[#29] Internal accounting for disability, indemnity, liability coverage and long-term personnel claims.

[#17] Incremental electricity/water for continuous HVAC, negative-pressure systems and equipment (annual surcharge).

[#22] Long-term surveillance for exposed personnel and contacts (CBCs, cultures, imaging, contact tracing).

[#23] Employee assistance, counseling, hazard pay differentials and related staff compensation programs.

[#30] LN2/freezer monitoring, power and routine maintenance for biobank and sample archives.